Developer docs
API playgroundTry for free, no card

Search company profiles

Elita

Full company profile

uuid0004h9l

Namestring
Elita
Legal namestring
Elita Genetics Operations Pty Ltd
Websiteurl
elita.pet
Company typeenum
Private
Founded yearint
2023
Descriptiontext

Elita is an Australian pet health technology company operating two integrated products: Elita Blueprint, a mobile longevity platform for dogs available on iOS and Android, and an autologous (pet's own) mesenchymal stem cell banking service processed at its in-house Melbourne laboratory. Blueprint unifies veterinary clinical records, owner observations, biomarker data, and check-ins into a single health profile, then applies a proprietary insight system to deliver predictive recommendations, care reminders, and an AI-powered chat interface (built on Google Cloud Vertex AI / Gemini on the paid tier). The company describes itself as the "world's first pet longevity platform" and "Australia's first dedicated pet stem cell bank." Its customer base comprises individual dog owners subscribing to the freemium app and Australian veterinarians participating in a Vet Portal referral and sample-collection network.

Elita monetises through two distinct streams. Blueprint offers a free tier plus a Premium subscription at A$8.99/month or A$89.99/year, unlocking unlimited insights, full health profiles, biomarker visualisations, and expanded in-app chat access. The stem cell banking service is sold as three tiers — Basic Banking (A$345 upfront plus A$16.50/month, 24-month minimum), Flex & Secure (A$849 upfront plus A$55/month capped at 5 years), and Set & Forget (A$3,899 one-time, lifetime storage) — with draws available for additional fees. Pricing is publicly disclosed and structured around a recurring-storage component for customer lock-in. The company sells directly to consumers via its website and app stores, and indirectly through veterinary partners who collect adipose tissue samples during routine procedures such as desexing.

The company is headquartered in Brunswick, Victoria, operates a processing lab in Melbourne, and serves only Australian customers for physical banking services, while the app subscription is available internationally. Elita is venture-backed, having closed a A$680,901 seed round in January 2025 led by LaunchVic with Archangel Ventures, M8 Ventures, Side Stage Ventures, Startmate, and XA Network participating. The leadership team combines commercial (CEO Paloma Newton) and technical (CTO Jackson Gritching, a biomedical engineer) founders with three PhD-level scientists covering stem cell science, biochemistry, and biobanking. The company is regulated under WSIAEC ethics approval and holds a DECCA research licence, with quality assurance described as exceeding standard veterinary practices.

Short descriptiontext

Elita operates an Australian pet longevity platform combining a mobile health app (Blueprint) with autologous canine stem cell banking. It serves dog owners via a freemium subscription and Australian veterinarians via a clinical referral network for biological sample collection.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersMelbourne, Australia
HQ citystring
Melbourne
HQ countrystring
Australia
HQ regionstring
Oceania
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pet longevity platform, dog stem cell banking, pet health tracking app, regenerative veterinary medicine, canine preventative healthcare
Industry2 codes
PRIMARYHLAMANAJ
Cryopreservation, Biobanking & Cell Banking (Cord/Adipose/MSC)
Healthcare & Life Sciences/Veterinary & Animal Health/Regenerative Medicine for Animals
SECONDARYHLAMANAA
Stem Cell Therapies (Autologous & Allogeneic)
Healthcare & Life Sciences/Veterinary & Animal Health/Regenerative Medicine for Animals
NAICS code1 code
  • Blood and Organ Banks621991
SIC code1 code
  • Biological Products, (No Disgnostic Substances)2836
Product category
Pet Health & Longevity Technology
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model5 records
1Blueprint App Premium Subscription
TypeSubscription Recurring
Description

Free app with Premium subscription tier ($8.99/month AUD or $89.99/year AUD) unlocking unlimited insights, full health profile, detailed biomarker visualisations, and fuller in-app chat access. 1-month free trial for new users.

elita.pet
2Stem Cell Banking - Basic Banking
TypeSubscription Recurring
Description

One-time upfront payment of $345 plus $16.50/month storage fee (24-month minimum contract). Covers sample-to-stem cell processing, courier delivery, and logistics. After 5 years of payments, lifetime storage included at no extra cost if joined by 30 Sept 2025.

elita.pet
3Stem Cell Banking - Flex & Secure
TypeSubscription Recurring
Description

One-time upfront payment of $849 (normally $994, saving $145). $55/month capped after 5 years for lifetime storage. Includes up to 10 draws from the stem cell bank. Covers processing, courier delivery both ways, and all logistics.

elita.pet
4Stem Cell Banking - Set & Forget
TypeOne Time License
Description

One-time upfront payment of $3,899 (normally $4,449, saving $550) if joining before 30 Sept 2025. Covers sample-to-stem cell processing, courier delivery, logistics, and lifetime storage. No ongoing fees. Lowest total lifetime cost.

elita.pet
5Stem Cell Draw Fees
TypeTransaction Fee
Description

Draws of stored stem cells are available upon request and veterinary prescription, with a fee applicable. Basic Banking plan requires separate draw fees.

elita.pet
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Pricing details5 tiers
1Free tier - Core app features at no cost
ModelFreemiumBilling cadenceMonthly
Notes

$5.99/month USD / $8.99/month AUD for the app. Free tier includes calendar, check-ins, reminders, observational notes, care prompts, Vet Records Concierge, health profile snapshot, limited insights/recommendations, and limited in-app chat interactions.

elita.pet
2Premium Blueprint - Unlimited insights and deeper AI chat
ModelSubscriptionBilling cadenceMonthly
Notes

$8.99/month AUD / $89.99/year AUD. Premium unlocks unlimited insights and recommendations across all health pillars, full health profile, detailed drill-downs on scores and biomarkers, biomarker visualisations (trends over time), fuller in-app chat access. New users get 1-month free trial.

elita.pet
3Basic Banking - Entry stem cell banking package
ModelSubscriptionBilling cadenceMonthly
Notes

$345 upfront + $16.50/month storage. 24-month minimum contract. Covers sample-to-stem cell processing, courier delivery from vet to bank, and all logistics. Draws available upon request with prescription for a fee.

elita.pet
4Flex & Secure - Mid-tier with capped storage
ModelSubscriptionBilling cadenceMonthly
Notes

$849 upfront (normally $994, save $145). $55/month capped after 5 years for lifetime storage. Includes up to 10 draws from the stem cell bank.

elita.pet
5Set & Forget - Best value one-time payment
ModelOne time/ perpetual licenseBilling cadenceMulti-year contract
Notes

$3,899 one-time payment (normally $4,449, save $550) if joining before 30 Sept 2025. Covers sample-to-stem cell processing, courier delivery, logistics, and lifetime storage. No ongoing fees.

elita.pet
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

Elita delivers a pet longevity platform consisting of the Blueprint mobile app (iOS/Android) and an autologous stem cell banking service for dogs. The Blueprint app unifies a dog's clinical records, owner observations, biomarkers, and lifestyle data into an AI-driven personalised health profile with predictive insights, recommendations, and a conversational AI chat, while the stem cell banking service collects, processes, and cryopreserves the dog's own mesenchymal stem cells in an Australian laboratory for future regenerative therapies.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 80% of dogs over 8 years estimated to have arthritis - early intervention through stem cell banking can help address this
+3 more records
Product overview1 text field

Elita is a pet longevity technology company operating two integrated core products: the Elita Blueprint app and Stem Cell Banking service. Blueprint is a digital health platform (mobile app on iOS/Android, with a web subscription option) that unifies a dog's clinical records, biological markers, owner observations, and lifestyle data into a single personalised Blueprint, powered by AI-driven predictive insights, recommendation engines, and an in-app AI chat feature. Stem Cell Banking is a biological storage service that collects, processes, and cryopreserves autologous mesenchymal stem cells from dogs during routine veterinary procedures, storing them for future therapeutic use. Additional offerings include a Vet Portal (supporting the veterinary network), Advanced Diagnostics (in development), and the Tailwinds educational blog. The company is headquartered in Melbourne, Australia, and is regulated under WSIAEC ethics approval.

Product and service4 records
1Elita Blueprint
CategoryPet health mobile application / digital health platform
Description

A mobile application (iOS/Android) and complementary web subscription serving as a digital health hub for dogs, unifying clinical records, biological markers, owner observations, and lifestyle data into a personalised longevity Blueprint with predictive insights, care reminders, Vet Records Concierge, AI-powered in-app chat, and biomarker tracking. Free tier available with optional Premium subscription upgrade.

2Stem Cell Banking
CategoryPet regenerative medicine / biological storage service
Description

An autologous stem cell banking service for dogs that collects mesenchymal stem cells (MSCs) from adipose tissue during routine procedures such as desexing. Samples are processed and cryopreserved in Elita's Melbourne laboratory with quality assurance, sterility testing, and a 10-vial guarantee per sample, stored for future regenerative therapies to treat conditions such as arthritis, dysplasia, and cruciate ligament injuries.

3Biological Age Calculator
CategoryPet health assessment / online tool
Description

A free online tool that estimates a dog's biological age by accounting for factors beyond chronological age, helping owners better assess their pet's health and ageing trajectory, and providing an entry point into the Blueprint platform.

4Vet Portal
CategoryVeterinary professional platform / partner enablement
Description

A dedicated portal for veterinarians providing access to peer-reviewed studies, webinars, audio libraries, team information, news, and FAQs, designed to support veterinary engagement with Elita's longevity platform and stem cell banking services.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
1Professor Wojciech Chrzanowski
Strategic tierAdvisoryTypeStrategic or Co-development Partner
Description

Nanoparticle Engineer at University of Sydney. Collaborating with Elita to deeply characterise stem cells to understand exactly what they're working with. This foundational understanding supports Elita's commitment to delivering robust, personalised treatments for every pet.

elita.pet
2Eva Orlowski-Oliver
Strategic tierAdvisoryTypeStrategic or Co-development Partner
Description

Flow Cytometry Specialist at Peter MacCallum Cancer Centre. Working with Elita to investigate proteins, growth factors, and biologicals produced by stem cells. By understanding their therapeutic potential, this helps inform how Elita tailors their approach to different diseases.

elita.pet
3WSIAEC (Wildlife and Small Institutions Animal Ethics Committee)
Strategic tierRegulatoryTypeOthers
Description

Independent ethics board governing Elita's biobank operations and research activities under DECCA research licence. Ensures all research and procedures meet strict ethical and scientific standards.

elita.pet
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

US-based pet stem cell banking company offering autologous MSC banking for dogs, founded with the explicit thesis of bringing regenerative medicine to companion animals. Closest direct peer to Elita's banking service, differentiated primarily by geography (US vs Australia) and stage.

TypeDirect peer
Description

Veterinary regenerative medicine company providing stem cell therapy kits and services to veterinary clinics, including adipose-derived MSC processing. Directly comparable to Elita on the cellular therapy side, though MediVet's model emphasises in-clinic point-of-care processing versus Elita's centralised cryobank.

3VetStem Biopharma
TypeDirect peer
Description

Pioneer in veterinary regenerative medicine offering autologous stem cell therapy for dogs, horses, and cats through a network of trained veterinary providers. Highly comparable on the canine stem cell service category and clinical application side.

TypeDirect peer
Description

Biotech company developing FDA-evaluated drugs to extend dog lifespan and healthspan. Comparable to Elita as a fellow 'dog longevity' category player, but operating via pharmaceutical therapeutics rather than biological banking and digital health platform.

5Whistle (Mars Petcare)
TypeBroad incumbent
Description

Pet wearable and health tracking platform owned by Mars Petcare, focused on activity, behaviour, and health monitoring for dogs and cats. Comparable as a broader pet health data platform, though it lacks the biological/banking component that defines Elita's differentiation.

TypeEmerging player
Description

Pet care platform offering appointment booking, reminders, records storage, and loyalty programs to veterinary clinics and pet owners. Comparable to Elita's Blueprint in the pet records and engagement layer, but lacking the biological asset and AI clinical insights.

7VitusVet
TypeEmerging player
Description

Veterinary practice management and client communication platform providing digital records, two-way messaging, and pet parent engagement tools. Overlaps with Elita's Vet Portal and Blueprint on the vet-owner communication and records management layer.

TypeBroad incumbent
Description

Global leader in animal health pharmaceuticals, diagnostics, and biologics for companion and livestock animals. A potential competitor and strategic acquirer in pet regenerative medicine, with the capital and distribution to enter or absorb Elita's category.

TypeBroad incumbent
Description

North American medical insurance provider for cats and dogs, increasingly bundling wellness and preventive offerings. Comparable as a premium pet wellness monetisation model, with the capital to expand into adjacent services like Elita's preventative longevity platform.

TypeRegional player
Description

Leading Australian pet insurance provider serving the same Australian dog owner segment as Elita. Comparable as a regional premium pet wellness monetisation channel and potential partnership or distribution counterparty in the Australian market.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration4 records

Each record includes

Title, Type, Description, Source

AI capability7 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors10 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Elita

Pet Health & Longevity Technologyelita.pet

Elita operates an Australian pet longevity platform combining a mobile health app (Blueprint) with autologous canine stem cell banking. It serves dog owners via a freemium subscription and Australian veterinarians via a clinical referral network for biological sample collection.

What Elita does

Elita is an Australian pet health technology company operating two integrated products: Elita Blueprint, a mobile longevity platform for dogs available on iOS and Android, and an autologous (pet's own) mesenchymal stem cell banking service processed at its in-house Melbourne laboratory. Blueprint unifies veterinary clinical records, owner observations, biomarker data, and check-ins into a single health profile, then applies a proprietary insight system to deliver predictive recommendations, care reminders, and an AI-powered chat interface (built on Google Cloud Vertex AI / Gemini on the paid tier). The company describes itself as the "world's first pet longevity platform" and "Australia's first dedicated pet stem cell bank." Its customer base comprises individual dog owners subscribing to the freemium app and Australian veterinarians participating in a Vet Portal referral and sample-collection network.

Elita monetises through two distinct streams. Blueprint offers a free tier plus a Premium subscription at A$8.99/month or A$89.99/year, unlocking unlimited insights, full health profiles, biomarker visualisations, and expanded in-app chat access. The stem cell banking service is sold as three tiers — Basic Banking (A$345 upfront plus A$16.50/month, 24-month minimum), Flex & Secure (A$849 upfront plus A$55/month capped at 5 years), and Set & Forget (A$3,899 one-time, lifetime storage) — with draws available for additional fees. Pricing is publicly disclosed and structured around a recurring-storage component for customer lock-in. The company sells directly to consumers via its website and app stores, and indirectly through veterinary partners who collect adipose tissue samples during routine procedures such as desexing.

The company is headquartered in Brunswick, Victoria, operates a processing lab in Melbourne, and serves only Australian customers for physical banking services, while the app subscription is available internationally. Elita is venture-backed, having closed a A$680,901 seed round in January 2025 led by LaunchVic with Archangel Ventures, M8 Ventures, Side Stage Ventures, Startmate, and XA Network participating. The leadership team combines commercial (CEO Paloma Newton) and technical (CTO Jackson Gritching, a biomedical engineer) founders with three PhD-level scientists covering stem cell science, biochemistry, and biobanking. The company is regulated under WSIAEC ethics approval and holds a DECCA research licence, with quality assurance described as exceeding standard veterinary practices.

Elita firmographics

Firmographics
Name
Elita
Legal name
Elita Genetics Operations Pty Ltd
Website
https://elita.pet
Company type
Private
Founded year
2023
Operating status
Operating
Headcount range
11–50 employees
Short description
Elita operates an Australian pet longevity platform combining a mobile health app (Blueprint) with autologous canine stem cell banking. It serves dog owners via a freemium subscription and Australian veterinarians via a clinical referral network for biological sample collection.
Ownership category
akta.pro rank

Elita industry classification

Industry
Product category
Pet Health & Longevity Technology
NAICS
Blood and Organ Banks (621991)
SIC
Biological Products, (No Disgnostic Substances) (2836)
akta.pro industry
PRIMARYHLAMANAJ
Cryopreservation, Biobanking & Cell Banking (Cord/Adipose/MSC)
Healthcare & Life Sciences/Veterinary & Animal Health/Regenerative Medicine for Animals
SECONDARYHLAMANAA
Stem Cell Therapies (Autologous & Allogeneic)
Healthcare & Life Sciences/Veterinary & Animal Health/Regenerative Medicine for Animals

Keywords

  • Pet longevity platform
  • Dog stem cell banking
  • Pet health tracking app
  • Regenerative veterinary medicine
  • Canine preventative healthcare

Where Elita is headquartered

Location

Headquarters

HQ city
Melbourne
HQ country
Australia
HQ region
Oceania

Offices2 records

Markets served

Elita business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Blueprint App Premium Subscription: Free app with Premium subscription tier ($8.99/month AUD or $89.99/year AUD) unlocking unlimited insights, full health profile, detailed biomarker visualisations, and fuller in-app chat access. 1-month free trial for new users.
  2. Stem Cell Banking - Basic Banking: One-time upfront payment of $345 plus $16.50/month storage fee (24-month minimum contract). Covers sample-to-stem cell processing, courier delivery, and logistics. After 5 years of payments, lifetime storage included at no extra cost if joined by 30 Sept 2025.
  3. Stem Cell Banking - Flex & Secure: One-time upfront payment of $849 (normally $994, saving $145). $55/month capped after 5 years for lifetime storage. Includes up to 10 draws from the stem cell bank. Covers processing, courier delivery both ways, and all logistics.
  4. Stem Cell Banking - Set & Forget: One-time upfront payment of $3,899 (normally $4,449, saving $550) if joining before 30 Sept 2025. Covers sample-to-stem cell processing, courier delivery, logistics, and lifetime storage. No ongoing fees. Lowest total lifetime cost.
  5. Stem Cell Draw Fees: Draws of stored stem cells are available upon request and veterinary prescription, with a fee applicable. Basic Banking plan requires separate draw fees.

Pricing tiers

ModelBillingPrice
FreemiumMonthlyFree tier - Core app features at no cost
SubscriptionMonthlyPremium Blueprint - Unlimited insights and deeper AI chat
SubscriptionMonthlyBasic Banking - Entry stem cell banking package
SubscriptionMonthlyFlex & Secure - Mid-tier with capped storage
One time/ perpetual licenseMulti-year contractSet & Forget - Best value one-time payment

Go-to-market motion1 record

Distribution channels4 records

Marketing channels8 records

Elita product offering

Product offering

Core offering

Elita delivers a pet longevity platform consisting of the Blueprint mobile app (iOS/Android) and an autologous stem cell banking service for dogs. The Blueprint app unifies a dog's clinical records, owner observations, biomarkers, and lifestyle data into an AI-driven personalised health profile with predictive insights, recommendations, and a conversational AI chat, while the stem cell banking service collects, processes, and cryopreserves the dog's own mesenchymal stem cells in an Australian laboratory for future regenerative therapies.

Product overview

Elita is a pet longevity technology company operating two integrated core products: the Elita Blueprint app and Stem Cell Banking service. Blueprint is a digital health platform (mobile app on iOS/Android, with a web subscription option) that unifies a dog's clinical records, biological markers, owner observations, and lifestyle data into a single personalised Blueprint, powered by AI-driven predictive insights, recommendation engines, and an in-app AI chat feature. Stem Cell Banking is a biological storage service that collects, processes, and cryopreserves autologous mesenchymal stem cells from dogs during routine veterinary procedures, storing them for future therapeutic use. Additional offerings include a Vet Portal (supporting the veterinary network), Advanced Diagnostics (in development), and the Tailwinds educational blog. The company is headquartered in Melbourne, Australia, and is regulated under WSIAEC ethics approval.

Differentiator

Problem solved

Functional benefit

Products and services

  • Elita Blueprint A mobile application (iOS/Android) and complementary web subscription serving as a digital health hub for dogs, unifying clinical records, biological markers, owner observations, and lifestyle data into a personalised longevity Blueprint with predictive insights, care reminders, Vet Records Concierge, AI-powered in-app chat, and biomarker tracking. Free tier available with optional Premium subscription upgrade.
  • Stem Cell Banking An autologous stem cell banking service for dogs that collects mesenchymal stem cells (MSCs) from adipose tissue during routine procedures such as desexing. Samples are processed and cryopreserved in Elita's Melbourne laboratory with quality assurance, sterility testing, and a 10-vial guarantee per sample, stored for future regenerative therapies to treat conditions such as arthritis, dysplasia, and cruciate ligament injuries.
  • Biological Age Calculator A free online tool that estimates a dog's biological age by accounting for factors beyond chronological age, helping owners better assess their pet's health and ageing trajectory, and providing an entry point into the Blueprint platform.
  • Vet Portal A dedicated portal for veterinarians providing access to peer-reviewed studies, webinars, audio libraries, team information, news, and FAQs, designed to support veterinary engagement with Elita's longevity platform and stem cell banking services.

Quantifiable outcome

  • 80% of dogs over 8 years estimated to have arthritis - early intervention through stem cell banking can help address this
  • +3 more outcomes

Companies that use Elita

Customer profile

Named customers6 records

Segments3 records

Ideal customer profiles2 records

Elita technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration4 records

AI capability7 records

Feature5 records

Elita partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered advisory and regulatory.

  • Professor Wojciech ChrzanowskiadvisoryStrategic or Co-development PartnerNanoparticle Engineer at University of Sydney. Collaborating with Elita to deeply characterise stem cells to understand exactly what they're working with. This foundational understanding supports Elita's commitment to delivering robust, personalised treatments for every pet.
  • Eva Orlowski-OliveradvisoryStrategic or Co-development PartnerFlow Cytometry Specialist at Peter MacCallum Cancer Centre. Working with Elita to investigate proteins, growth factors, and biologicals produced by stem cells. By understanding their therapeutic potential, this helps inform how Elita tailors their approach to different diseases.
  • WSIAEC (Wildlife and Small Institutions Animal Ethics Committee)regulatoryOthersIndependent ethics board governing Elita's biobank operations and research activities under DECCA research licence. Ensures all research and procedures meet strict ethical and scientific standards.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

Elita competitors and assessment

Company assessment

Direct peers

  • Gallant: US-based pet stem cell banking company offering autologous MSC banking for dogs, founded with the explicit thesis of bringing regenerative medicine to companion animals. Closest direct peer to Elita's banking service, differentiated primarily by geography (US vs Australia) and stage.
  • MediVet Biologics: Veterinary regenerative medicine company providing stem cell therapy kits and services to veterinary clinics, including adipose-derived MSC processing. Directly comparable to Elita on the cellular therapy side, though MediVet's model emphasises in-clinic point-of-care processing versus Elita's centralised cryobank.
  • VetStem Biopharma: Pioneer in veterinary regenerative medicine offering autologous stem cell therapy for dogs, horses, and cats through a network of trained veterinary providers. Highly comparable on the canine stem cell service category and clinical application side.
  • Loyal for Dogs: Biotech company developing FDA-evaluated drugs to extend dog lifespan and healthspan. Comparable to Elita as a fellow 'dog longevity' category player, but operating via pharmaceutical therapeutics rather than biological banking and digital health platform.

Broad incumbents

  • Whistle (Mars Petcare): Pet wearable and health tracking platform owned by Mars Petcare, focused on activity, behaviour, and health monitoring for dogs and cats. Comparable as a broader pet health data platform, though it lacks the biological/banking component that defines Elita's differentiation.
  • Zoetis: Global leader in animal health pharmaceuticals, diagnostics, and biologics for companion and livestock animals. A potential competitor and strategic acquirer in pet regenerative medicine, with the capital and distribution to enter or absorb Elita's category.
  • Trupanion: North American medical insurance provider for cats and dogs, increasingly bundling wellness and preventive offerings. Comparable as a premium pet wellness monetisation model, with the capital to expand into adjacent services like Elita's preventative longevity platform.

Emerging players

  • PetDesk: Pet care platform offering appointment booking, reminders, records storage, and loyalty programs to veterinary clinics and pet owners. Comparable to Elita's Blueprint in the pet records and engagement layer, but lacking the biological asset and AI clinical insights.
  • VitusVet: Veterinary practice management and client communication platform providing digital records, two-way messaging, and pet parent engagement tools. Overlaps with Elita's Vet Portal and Blueprint on the vet-owner communication and records management layer.

Regional players

  • Petplan Australia: Leading Australian pet insurance provider serving the same Australian dog owner segment as Elita. Comparable as a regional premium pet wellness monetisation channel and potential partnership or distribution counterparty in the Australian market.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Elita social profiles

Digital presence

Elita financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Elita leadership team

Management profile

Number of profiles

Profiles5 records

Elita funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors10 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Elita M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Elita

What does Elita do?

Elita delivers a pet longevity platform consisting of the Blueprint mobile app (iOS/Android) and an autologous stem cell banking service for dogs. The Blueprint app unifies a dog's clinical records, owner observations, biomarkers, and lifestyle data into an AI-driven personalised health profile with predictive insights, recommendations, and a conversational AI chat, while the stem cell banking service collects, processes, and cryopreserves the dog's own mesenchymal stem cells in an Australian laboratory for future regenerative therapies.

Is Elita a public or private company?

Elita is a private company. It is classified as venture growth investor backed and is currently operating.

When was Elita founded?

Elita was founded in 2023. It employs 11 to 50 people.

Where is Elita based?

Elita is headquartered in Melbourne, Australia, in the Oceania region.

How does Elita make money?

Five revenue lines are on record. Blueprint App Premium Subscription is the primary driver. The others are stem Cell Banking - Basic Banking, stem Cell Banking - Flex & Secure, stem Cell Banking - Set & Forget and stem Cell Draw Fees.

Who are Elita's main competitors?

Direct peers on record are Gallant, MediVet Biologics, VetStem Biopharma and Loyal for Dogs. Broad incumbents are Whistle (Mars Petcare), Zoetis and Trupanion. Emerging players are PetDesk and VitusVet. Petplan Australia is listed as a regional player.

Does Elita have an API?

No public API is recorded for Elita.

What industry is Elita in?

Elita's product category is Pet Health & Longevity Technology. Its primary akta.pro industry code is HLAMANAJ, Cryopreservation, Biobanking & Cell Banking (Cord/Adipose/MSC), with a secondary code of HLAMANAA, Stem Cell Therapies (Autologous & Allogeneic). Its NAICS code is 621991 and its SIC code is 2836.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals